QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Nordic HTA submissions
Are you looking for a partner to provide support in Nordic HTA submissions? QUANTIFY is a true pan-Nordic vendor with hands-on expertise in all Nordic countries combined with experience developing Global HEOR material, in addition to local offices and in-house local language competence.
QUANTIFY can support your Nordic launch from early market understanding and strategic planning, to preparation of HTA submission material with strategic input during the process, and post […]
SHEA annual conference 25–26 april
Quantify Research will attend this year’s annual SHEA-conference (Swedish Health Economic Association) in Stockholm on Tuesday and Wednesday (April 25th-26th). Our Nordic HTA experts Lena Jacobs, Hannah Norman and Konstantin Macheridis will participate in this year’s conference. Lena will take part in session 2A with the topic “Reimbursement decisions and payment models for drugs”, with a presentation on ”Restrictions and national price agreements […]
Nordic Rare Disease Summit 2023
We had a great time at the Nordic Rare Disease Summit 2023 last week, where important topics such as early diagnosis, patient empowerment, access to innovative treatments and EU legislation were discussed. It was a valuable opportunity to listen to insightful discussions about rare diseases in a multi-stakeholder setting, to connect with like-minded professionals and to hear the powerful stories of […]
Greta Bütepage Uggla joins Quantify!
Today we are proud to introduce Greta Bütepage Uggla who will strengthen our Modelling, Access and Strategy team in Stockholm as Lead Analyst. Greta is specialized in health economics and data analytics, with experience in health economic modeling, data analysis and visualization, register-based research, and project management. Her experience coupled with her enthusiasm for contributing to the field of health economics, will make her a valuable asset to […]